NYSE:SPNV

Supernova Partners Acquisition Competitors

$10.02
-0.04 (-0.40 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.00
Now: $10.02
$10.07
50-Day Range
$10.02
MA: $10.44
$12.15
52-Week Range
$9.93
Now: $10.02
$13.00
Volume604,332 shs
Average Volume770,308 shs
Market Capitalization$504.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Supernova Partners Acquisition (NYSE:SPNV) Vs. AJAX, AJAX, BTWN, BOWX, CMLF, and BOAC

Should you be buying SPNV stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Supernova Partners Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), BowX Acquisition (BOWX), CM Life Sciences (CMLF), and Bluescape Opportunities Acquisition (BOAC).

Supernova Partners Acquisition (NYSE:SPNV) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

Profitability

This table compares Supernova Partners Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Supernova Partners AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Supernova Partners Acquisition and Ajax I, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Supernova Partners Acquisition0000N/A
Ajax I0000N/A

Valuation & Earnings

This table compares Supernova Partners Acquisition and Ajax I's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supernova Partners AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Supernova Partners Acquisition (NYSE:SPNV) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Supernova Partners Acquisition and Ajax I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Supernova Partners Acquisition0000N/A
Ajax I0000N/A

Valuation & Earnings

This table compares Supernova Partners Acquisition and Ajax I's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supernova Partners AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Profitability

This table compares Supernova Partners Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Supernova Partners AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Bridgetown (NASDAQ:BTWN) and Supernova Partners Acquisition (NYSE:SPNV) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Analyst Ratings

This is a summary of recent recommendations and price targets for Bridgetown and Supernova Partners Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Supernova Partners Acquisition0000N/A

Profitability

This table compares Bridgetown and Supernova Partners Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Supernova Partners AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares Bridgetown and Supernova Partners Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Supernova Partners AcquisitionN/AN/AN/AN/AN/A

BowX Acquisition (NASDAQ:BOWX) and Supernova Partners Acquisition (NYSE:SPNV) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares BowX Acquisition and Supernova Partners Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Supernova Partners AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for BowX Acquisition and Supernova Partners Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Supernova Partners Acquisition0000N/A

Profitability

This table compares BowX Acquisition and Supernova Partners Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Supernova Partners AcquisitionN/AN/AN/A

Supernova Partners Acquisition (NYSE:SPNV) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Earnings and Valuation

This table compares Supernova Partners Acquisition and CM Life Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supernova Partners AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Profitability

This table compares Supernova Partners Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Supernova Partners AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Supernova Partners Acquisition and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Supernova Partners Acquisition0000N/A
CM Life Sciences0000N/A

Supernova Partners Acquisition (NYSE:SPNV) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Supernova Partners Acquisition and Bluescape Opportunities Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Supernova Partners Acquisition0000N/A
Bluescape Opportunities Acquisition0000N/A

Profitability

This table compares Supernova Partners Acquisition and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Supernova Partners AcquisitionN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Earnings and Valuation

This table compares Supernova Partners Acquisition and Bluescape Opportunities Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supernova Partners AcquisitionN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A


Supernova Partners Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.11-1.1%$904.27 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.11-1.1%$904.27 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$11.08-6.8%$824.06 millionN/A0.00
BOWX
BowX Acquisition
0.0$13.58-4.3%$819.89 millionN/A0.00Increase in Short Interest
CMLF
CM Life Sciences
0.0$14.58-2.9%$806.92 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.17-0.2%$772.29 millionN/A0.00Decrease in Short Interest
TPGY
TPG Pace Beneficial Finance
0.3$17.07-6.0%$746.81 millionN/A0.00
VYGG
Vy Global Growth
0.0$10.27-0.7%$738.16 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.18-1.3%$674.87 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.41-0.0%$670.14 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$10.08-1.3%$630 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.84-0.9%$615 millionN/A0.00
VSPR
Vesper Healthcare Acquisition
1.7$10.56-0.4%$607.20 millionN/A0.00Analyst Report
Decrease in Short Interest
News Coverage
HAAC
Health Assurance Acquisition
0.0$10.64-0.6%$589.19 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.16-0.1%$572.01 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$9.97-0.2%$571.78 millionN/A0.00News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.04-0.2%$564.75 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$8.41-2.4%$534.88 millionN/A0.00Increase in Short Interest
MOTV
Motive Capital
0.0$10.03-0.1%$519.05 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.81-0.2%$515.73 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.95-0.0%$514.91 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.96-1.6%$509.08 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.90-1.1%$507.01 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$10.00-0.2%$503.13 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.05-2.1%$502.50 millionN/A0.00
GMII
Gores Metropoulos II
0.0$10.03-0.1%$501.50 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$11.02-0.4%$495.90 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$12.49-13.1%$493.74 millionN/A0.00High Trading Volume
Unusual Options Activity
News Coverage
Gap Down
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.27-0.3%$473.45 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$10.90-1.8%$470.06 millionN/A0.00High Trading Volume
NGAC
NextGen Acquisition
0.0$9.99-0.0%$468.28 millionN/A0.00Increase in Short Interest
GHVI
Gores Holdings VI
0.0$13.52-0.9%$466.44 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.99-0.2%$456.92 millionN/A0.00Decrease in Short Interest
LUXA
Lux Health Tech Acquisition
0.0$10.42-0.0%$449.36 millionN/A0.00Decrease in Short Interest
RMGB
RMG Acquisition Co. II
0.0$10.00-0.7%$431.25 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.92-0.6%$427.80 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.90-0.8%$426.94 millionN/A0.00News Coverage
FSRV
FinServ Acquisition
0.0$13.37-1.3%$426.70 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.60-0.0%$413.43 millionN/A0.00
NSTB
Northern Star Investment Corp. II
0.0$10.05-0.3%$402 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.89-0.2%$400.65 millionN/A0.00Decrease in Short Interest
HOL
Holicity
0.0$10.65-1.0%$399.38 millionN/A0.00Increase in Short Interest
RAAC
Revolution Acceleration Acquisition
0.0$10.26-0.3%$393.30 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.47-1.4%$392.63 millionN/A0.00Increase in Short Interest
VIH
VPC Impact Acquisition
0.3$14.99-4.9%$388.57 millionN/A0.00Gap Down
XPOA
DPCM Capital
0.0$10.02-0.1%$387.02 millionN/A0.00Increase in Short Interest
KVSA
Khosla Ventures Acquisition
0.0$10.47-0.2%$375.87 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$9.95-0.3%$373.13 millionN/A0.00Decrease in Short Interest
PRSR
Prospector Capital
0.0$9.87-0.1%$369.94 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.85-0.1%$369.38 millionN/A0.00
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.